Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values-laboratory and clinical utility

被引:11
|
作者
Kahlmeter, Gunnar [1 ,2 ,3 ]
Turnidge, John [4 ,5 ]
机构
[1] European Comm Antimicrobial Susceptibil Testing EU, Vaxjo, Sweden
[2] Swedish Reference Lab Phenotyp Susceptibil Testing, Vaxjo, Sweden
[3] EUCAST Dev Lab, Vaxjo, Sweden
[4] European Comm Antimicrobial Susceptibil Testing EU, Document & Tech Support, Vaxjo, Sweden
[5] Univ Adelaide, Sch Biol Sci, Adelaide, Australia
关键词
ECOFF; epidemiological cut-off value; antimicrobial susceptibility testing; AST; phenotypic wild-type distribution; ECV; MYCOBACTERIUM-TUBERCULOSIS; SUSCEPTIBILITY; EUCAST; BREAKPOINTS; BACTERIA; ECOFFS;
D O I
10.1128/cmr.00100-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The characterization of wild-type minimum inhibitory concentration (MIC) and zone diameter distributions with the setting of epidemiological cut-off values (ECOFFs or ECVs) provides a reference for the otherwise relative MIC values in the international system for antimicrobial susceptibility testing. Distributions of MIC values for a species and an agent follow a log-normal distribution, which in the absence of resistance mechanisms is monomodal and designated wild type (WT). The upper end of the WT distribution, the ECOFF, can be identified with statistical methods. In the presence of phenotypically detectable resistance, the distribution has at least one more mode (the non-WT), but despite this, the WT is most often identifiable using the same methods. The ECOFF provides the most sensitive measure of resistance development in a species against an agent. The WT and non-WT modes are independent of the organism ' s response to treatment, but when the European Committee on Antimicrobial Susceptibility Testing (EUCAST) determines the clinical breakpoints, the committee avoids breakpoints that split WT distributions of target species. This is to avoid the poorer reproducibility of susceptibility categorization when breakpoints split major populations but also because the EUCAST has failed to identify different clinical outcomes for isolates with different MIC values inside the wild-type distribution. In laboratory practice, the ECOFF is used to screen for and exclude resistance and allows the comparison of resistance between systems with different breakpoints from different breakpoint organizations, breakpoints evolving over time, and different breakpoints between human and animal medicine. The EUCAST actively encourages colleagues to question MIC distributions as presented on the website (https://www.eucast.org/mic_and_zone_distributions_and_ecoffs) and to contribute MIC and inhibition zone diameter data.
引用
收藏
页数:14
相关论文
共 43 条
  • [31] Wild-Type MIC Distributions and Epidemiological Cutoff Values for Caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
    Espinel-Ingroff, A.
    Fothergill, A.
    Fuller, J.
    Johnson, E.
    Pelaez, T.
    Turnidge, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) : 2855 - 2859
  • [32] Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine
    Espinel-Ingroff, A.
    Chowdhary, A.
    Cuenca-Estrella, M.
    Fothergill, A.
    Fuller, J.
    Hagen, F.
    Govender, N.
    Guarro, J.
    Johnson, E.
    Lass-Floerl, C.
    Lockhart, S. R.
    Martins, M. A.
    Meis, J. F.
    Melhem, M. S. C.
    Ostrosky-Zeichner, L.
    Pelaez, T.
    Pfaller, M. A.
    Schell, W. A.
    Trilles, L.
    Kidd, S.
    Turnidge, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 3107 - 3113
  • [33] Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10
    Sturegard, E.
    Angeby, K. A.
    Werngren, J.
    Jureen, P.
    Kronvall, G.
    Giske, C. G.
    Kahlmeter, G.
    Schon, T.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (02) : 148.e5 - 148.e7
  • [34] Clinical effect of obesity on N-terminal pro-B-type natriuretic peptide cut-off concentrations for the diagnosis of acute heart failure
    Kozhuharov, Nikola
    Martin, Jasmin
    Wussler, Desiree
    Lopez-Ayala, Pedro
    Belkin, Maria
    Strebel, Ivo
    Flores, Dayana
    Diebold, Matthias
    Shrestha, Samyut
    Nowak, Albina
    Gualandro, Danielle M.
    Michou, Eleni
    Zimmermann, Tobias
    Rentsch, Katharina
    von Eckardstein, Arnold
    Keller, Dagmar, I
    Breidthardt, Tobias
    Mueller, Christian
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1545 - 1554
  • [35] Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
    Espinel-Ingroff, A.
    Diekema, D. J.
    Fothergill, A.
    Johnson, E.
    Pelaez, T.
    Pfaller, M. A.
    Rinaldi, M. G.
    Canton, E.
    Turnidge, J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (09) : 3251 - 3257
  • [36] Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
    Espinel-Ingroff, A.
    Cuenca-Estrella, M.
    Fothergill, A.
    Fuller, J.
    Ghannoum, M.
    Johnson, E.
    Pelaez, T.
    Pfaller, M. A.
    Turnidge, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (11) : 5150 - 5154
  • [37] Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole
    Espinel-Ingroff, A.
    Aller, A. I.
    Canton, E.
    Castanon-Olivares, L. R.
    Chowdhary, A.
    Cordoba, S.
    Cuenca-Estrella, M.
    Fothergill, A.
    Fuller, J.
    Govender, N.
    Hagen, F.
    Illnait-Zaragozi, M. T.
    Johnson, E.
    Kidd, S.
    Lass-Floerl, C.
    Lockhart, S. R.
    Martins, M. A.
    Meis, J. F.
    Melhem, M. S. C.
    Ostrosky-Zeichner, L.
    Pelaez, T.
    Pfaller, M. A.
    Schell, W. A.
    St-Germain, G.
    Trilles, L.
    Turnidge, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5898 - 5906
  • [38] Cut-off Values and Clinical Utility of Surrogate Markers for Insulin Resistance and Beta-Cell Function to Identify Metabolic Syndrome and Its Components among Southern Indian Adults
    Endukuru, Chiranjeevi Kumar
    Gaur, Girwar Singh
    Yerrabelli, Dhanalakshmi
    Sahoo, Jayaprakash
    Vairappan, Balasubramaniyan
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2020, 29 (04) : 281 - 291
  • [39] Using clinical outcomes to refine laboratory QA practices: Modulation of cut-off values and positivity rates to optimize PPV in prenatal screening for open neural tube defects.
    Harrison, H
    Miller, R
    Gooding, C
    Jaffe, B
    McNamara, K
    Winter, L
    CLINICAL CHEMISTRY, 1996, 42 (06) : 589 - 589
  • [40] Higher target attainment for B-lactam antibiotics in patients with Gram-negative bloodstream infections when four times actual minimum inhibitory concentrations and epidemiological cutoff values are applied compared to clinical breakpoints
    Lejbman, Ilja Areskog
    Torisson, Gustav
    Resman, Fredrik
    Sjoevall, Fredrik
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2025,